Clinical Trials Sponsored by Harimata

Total 25 results

Haramaya Unversity

Completed

The Uncommon Complications of Meckel's Diverticulum (MD)

To Report the Rare Occurrence of Meckel's Diverticulum

Ethiopia
Haramaya Unversity

Completed

Causes of Complicated Appendicitis at Referral Hospital (AA)

Complicated Appendicitis

Ethiopia
Haramaya Unversity

Completed

Pattern of Admission and Outcome of Patients Admitted to the Intensive Care (ICU)

Respiratory Failure | Treatment Outcome

Ethiopia
Haramaya Unversity

Completed

Surgical Outcome at HFSUH (POC)

Surgical Outcome

Ethiopia
Haramaya Unversity

Completed

Acceptability and Effectiveness of Household Water Treatment in Reducing Diarrhea Among Under Five Children

Acute Diarrhoea

Ethiopia
Haramaya Unversity

Completed

Poorly Differentiated Adenocarcinoma of the Jejunum in a Patient With Peutz-Jeghers Syndrome: A Case Report

Peutz-Jeghers Syndrome

Ethiopia
Haramaya Unversity

Completed

Magnitude, Types, and Associated Factors of External Abdominal Hernias Among Adult Patients Visiting the Surgical Outpatient Department at Hiwotfana Comprehensive Specialized Hospital and Jugol Regional Hospital, Eastern Ethiopia: A Cross-Sectional Study

Abdominal Wall Hernia

Ethiopia
Armata Pharmaceuticals, Inc.

Completed

Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults

Dental Caries

United States
Armata Pharmaceuticals, Inc.

Completed

Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses

Dental Caries

United States
Armata Pharmaceuticals, Inc.

Completed

Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects

Dental Caries

United States
Armata Pharmaceuticals, Inc.

No longer available

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic
Armata Pharmaceuticals, Inc.

Recruiting

Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection (Tailwind)

Pseudomonas Aeruginosa | Lung Infection | Non-cystic Fibrosis Bronchiectasis

United States
Armata Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects

Dental Caries

United States
Armata Pharmaceuticals, Inc.

Completed

A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects (C3J17-206-00)

Dental Caries

United States
Armata Pharmaceuticals, Inc.

No longer available

Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic
University of Strathclyde
Göteborg University; University of Aberdeen; University of Glasgow; Harimata

Unknown

Early Assessment of Autism Through Smart Tablet Gameplay

Autism Spectrum Disorder | Other Neurodevelopmental Disorder

Sweden, United Kingdom
Haramaya Unversity
University of Ghana; World Health Organization

Unknown

Community Based Intervention to Prevent Domestic Violence Against Women in Ethiopia; a Protocol for Quasi-Experimental Implementation Research

Domestic Violence Against Women | Community-based Prevention | Interevntion Implementation

Ethiopia
Armata Pharmaceuticals, Inc.
Cystic Fibrosis Foundation

Completed

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis (SWARM-Pa)

Cystic Fibrosis | Pseudomonas Aeruginosa | Lung Infection | Pseudomonas | Lung Infection Pseudomonal

United States
Haramaya Unversity
University of Copenhagen; Leiden University Medical Center; Laerdal Foundation

Recruiting

Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach (PartoMa-Eth)

Obstetric Complication | Perinatal Death | Maternal Death | Stillbirth | Perinatal Morbidity

Ethiopia
Armata Pharmaceuticals, Inc.
United States Department of Defense

Recruiting

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (diSArm)

Bacteremia | Staphylococcus Aureus | Staphylococcus Aureus Bacteremia | Bacteremia Due to Staphylococcus Aureus | Bacteremia Staph

United States, Australia
Armata Pharmaceuticals, Inc.
Walter Reed Army Institute of Research (WRAIR)

Completed

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

Healthy Volunteers

United States
Armata Pharmaceuticals, Inc.
SynteractHCR; Agility Clinical, Inc.; Vantage Data Designs, Inc.

Completed

Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects

Dental Caries

United States
Adwin Life Care
Sonal Foundation, India; Gyaansanjeevani, Jhunjhunu, Rajasthan, India; Khatri...

Completed

Nursing Led Interdisciplinary Intervention in Prevention of Girl Child Mortality and Maltreatment

Abuse Neglect Social | Deprivation, Maltreatment Syndrome (Infant or Child)

India
Armata Pharmaceuticals, Inc.
Agility Clinical, Inc.; Vantage Data Designs, Inc.; E Squared Trials and Registries...

Completed

A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application

Dental Caries

United States
Oslo University Hospital
The Research Council of Norway; University of Agder; Addis Ababa University; St... and other collaborators

Active, not recruiting

Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa

Hepatitis B

Ethiopia

Clinical Trials Sponsored by Harimata

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations